Intuitive Surgical (NASDAQ:ISRG) Trading Up 1.9% – Still a Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock price was up 1.9% on Monday . The stock traded as high as $544.84 and last traded at $544.21. Approximately 2,039,467 shares traded hands during mid-day trading, a decline of 4% from the average daily volume of 2,119,726 shares. The stock had previously closed at $534.28.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on ISRG shares. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Daiwa Capital Markets lifted their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Mizuho set a $575.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Finally, BTIG Research lifted their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Stock Up 1.9%

The company has a fifty day simple moving average of $464.32 and a 200-day simple moving average of $498.73. The firm has a market cap of $195.09 billion, a P/E ratio of 71.99, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The business’s revenue was up 22.9% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 125 shares of the company’s stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $543.00, for a total transaction of $67,875.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 96,011 shares of company stock valued at $50,309,042. Corporate insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Trifecta Capital Advisors LLC lifted its holdings in shares of Intuitive Surgical by 4.8% during the 3rd quarter. Trifecta Capital Advisors LLC now owns 14,014 shares of the medical equipment provider’s stock valued at $6,267,000 after purchasing an additional 646 shares during the last quarter. Alpha Cubed Investments LLC raised its stake in Intuitive Surgical by 13.0% in the 3rd quarter. Alpha Cubed Investments LLC now owns 92,600 shares of the medical equipment provider’s stock worth $41,413,000 after acquiring an additional 10,677 shares during the last quarter. Valley Wealth Managers Inc. raised its stake in Intuitive Surgical by 52.7% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after acquiring an additional 1,409 shares during the last quarter. Tandem Investment Advisors Inc. raised its stake in Intuitive Surgical by 4.5% in the 3rd quarter. Tandem Investment Advisors Inc. now owns 9,219 shares of the medical equipment provider’s stock worth $4,123,000 after acquiring an additional 396 shares during the last quarter. Finally, Strategic Advisors LLC raised its stake in Intuitive Surgical by 63.3% in the 3rd quarter. Strategic Advisors LLC now owns 10,397 shares of the medical equipment provider’s stock worth $4,650,000 after acquiring an additional 4,031 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.